Analyst Ratings For Audentes Therapeutics Inc (NASDAQ:BOLD)
Today, HC Wainwright reiterated its Buy rating on Audentes Therapeutics Inc (NASDAQ:BOLD) with a price target of $44.00.
There are 7 Buy Ratings, 3 Hold Ratings, 1 Sell Ratings, no Strong Buy Ratings on the stock.
The current consensus rating on Audentes Therapeutics Inc (NASDAQ:BOLD) is Buy with a consensus target price of $33.99 per share, a potential 11.00% downside.
Some recent analyst ratings include
- 3/18/2019-Audentes Therapeutics Inc (NASDAQ:BOLD) had its Buy rating reiterated by HC Wainwright with a $44.00 price target
- 2/27/2019-Audentes Therapeutics Inc (NASDAQ:BOLD) had its Hold rating reiterated by William Blair
- 2/25/2019-Audentes Therapeutics Inc (NASDAQ:BOLD) gets upgraded to Buy by Chardan Capital with a price target of $40.00
- 2/1/2019-Audentes Therapeutics Inc (NASDAQ:BOLD) had its Buy rating reiterated by Mizuho with a $45.00 price target
- 1/31/2019-Audentes Therapeutics Inc (NASDAQ:BOLD) had its Buy rating reiterated by Cowen
- 1/11/2019-Audentes Therapeutics Inc (NASDAQ:BOLD) gets upgraded to Buy by Guggenheim with a price target of $35.00
- On 2/25/2019 Matthew R Patterson, CEO, sold 21,000 with an average share price of $30.00 per share and the total transaction amounting to $630,000.00.
- On 2/25/2019 Suyash Prasad, VP, sold 10,000 with an average share price of $30.06 per share and the total transaction amounting to $300,600.00.
- On 12/24/2018 Louis G Lange, Director, sold 32,000 with an average share price of $18.62 per share and the total transaction amounting to $595,840.00.
- On 11/15/2018 Louis G Lange, Director, sold 24,000 with an average share price of $22.49 per share and the total transaction amounting to $539,760.00.
- On 10/1/2018 Matthew R Patterson, CEO, sold 21,000 with an average share price of $38.16 per share and the total transaction amounting to $801,360.00.
- On 10/1/2018 Suyash Prasad, VP, sold 10,000 with an average share price of $36.88 per share and the total transaction amounting to $368,800.00.
- On 9/28/2018 John T Gray, SVP, sold 87 with an average share price of $40.00 per share and the total transaction amounting to $3,480.00.
Recent Trading Activity for Audentes Therapeutics Inc (NASDAQ:BOLD)
Shares of Audentes Therapeutics Inc closed the previous trading session at 38,19 up +1,53 4,17 % with 39.1 shares trading hands.